CARBIOS (ALCRB.PA) Fundamental Analysis & Valuation

EPA:ALCRB • FR0011648716

Current stock price

7.975 EUR
+0.02 (+0.31%)
Last:

This ALCRB.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ALCRB.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALCRB has reported negative net income.
  • In the past year ALCRB has reported a negative cash flow from operations.
  • In the past 5 years ALCRB reported 4 times negative net income.
  • In the past 5 years ALCRB always reported negative operating cash flow.
ALCRB.PA Yearly Net Income VS EBIT VS OCF VS FCFALCRB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

  • ALCRB has a Return On Assets of -16.01%. This is amonst the worse of the industry: ALCRB underperforms 82.86% of its industry peers.
  • ALCRB has a worse Return On Equity (-21.99%) than 81.43% of its industry peers.
Industry RankSector Rank
ROA -16.01%
ROE -21.99%
ROIC N/A
ROA(3y)-11.97%
ROA(5y)-10.26%
ROE(3y)-16.77%
ROE(5y)-14.67%
ROIC(3y)N/A
ROIC(5y)N/A
ALCRB.PA Yearly ROA, ROE, ROICALCRB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ALCRB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALCRB.PA Yearly Profit, Operating, Gross MarginsALCRB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K -100K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ALCRB.PA Health Analysis

2.1 Basic Checks

  • ALCRB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALCRB has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ALCRB has been increased compared to 5 years ago.
  • The debt/assets ratio for ALCRB has remained at the same level compared to a year ago.
ALCRB.PA Yearly Shares OutstandingALCRB.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ALCRB.PA Yearly Total Debt VS Total AssetsALCRB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • ALCRB has an Altman-Z score of 0.32. This is a bad value and indicates that ALCRB is not financially healthy and even has some risk of bankruptcy.
  • ALCRB's Altman-Z score of 0.32 is on the low side compared to the rest of the industry. ALCRB is outperformed by 82.86% of its industry peers.
  • A Debt/Equity ratio of 0.19 indicates that ALCRB is not too dependend on debt financing.
  • ALCRB has a Debt to Equity ratio of 0.19. This is in the better half of the industry: ALCRB outperforms 67.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 0.32
ROIC/WACCN/A
WACC7.13%
ALCRB.PA Yearly LT Debt VS Equity VS FCFALCRB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • ALCRB has a Current Ratio of 3.84. This indicates that ALCRB is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of ALCRB (3.84) is better than 94.29% of its industry peers.
  • ALCRB has a Quick Ratio of 3.79. This indicates that ALCRB is financially healthy and has no problem in meeting its short term obligations.
  • ALCRB's Quick ratio of 3.79 is amongst the best of the industry. ALCRB outperforms 97.14% of its industry peers.
Industry RankSector Rank
Current Ratio 3.84
Quick Ratio 3.79
ALCRB.PA Yearly Current Assets VS Current LiabilitesALCRB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALCRB.PA Growth Analysis

3.1 Past

  • ALCRB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.78%.
  • The Revenue has grown by 655.84% in the past year. This is a very strong growth!
  • ALCRB shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -37.71% yearly.
EPS 1Y (TTM)-17.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.12%
Revenue 1Y (TTM)655.84%
Revenue growth 3Y9.01%
Revenue growth 5Y-37.71%
Sales Q2Q%610.96%

3.2 Future

  • Based on estimates for the next years, ALCRB will show a very strong growth in Earnings Per Share. The EPS will grow by 27.01% on average per year.
  • The Revenue is expected to grow by 300.17% on average over the next years. This is a very strong growth
EPS Next Y-0.64%
EPS Next 2Y13.56%
EPS Next 3Y8.07%
EPS Next 5Y27.01%
Revenue Next Year316.67%
Revenue Next 2Y356.44%
Revenue Next 3Y278.37%
Revenue Next 5Y300.17%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALCRB.PA Yearly Revenue VS EstimatesALCRB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
ALCRB.PA Yearly EPS VS EstimatesALCRB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 6

More info and screens

Find the best growth stocksShow best growing peers

0

4. ALCRB.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALCRB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALCRB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCRB.PA Price Earnings VS Forward Price EarningsALCRB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCRB.PA Per share dataALCRB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.56%
EPS Next 3Y8.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALCRB.PA Dividend Analysis

5.1 Amount

  • ALCRB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALCRB.PA Fundamentals: All Metrics, Ratios and Statistics

CARBIOS

EPA:ALCRB (3/17/2026, 7:00:00 PM)

7.975

+0.02 (+0.31%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)09-24
Earnings (Next)04-08
Inst Owners15.07%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap134.86M
Revenue(TTM)582.00K
Net Income(TTM)-38.57M
Analysts40
Price Target12.24 (53.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-3.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)100%
Revenue NY rev (3m)100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 231.71
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 1.01
EV/EBITDA N/A
EPS(TTM)-2.29
EYN/A
EPS(NY)-1.61
Fwd EYN/A
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)-1.79
OCFYN/A
SpS0.03
BVpS10.37
TBVpS7.9
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -16.01%
ROE -21.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-11.97%
ROA(5y)-10.26%
ROE(3y)-16.77%
ROE(5y)-14.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 213.71%
Cap/Sales 5553.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.84
Quick Ratio 3.79
Altman-Z 0.32
F-Score3
WACC7.13%
ROIC/WACCN/A
Cap/Depr(3y)437.01%
Cap/Depr(5y)449.88%
Cap/Sales(3y)53289.6%
Cap/Sales(5y)34828.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-30.12%
EPS Next Y-0.64%
EPS Next 2Y13.56%
EPS Next 3Y8.07%
EPS Next 5Y27.01%
Revenue 1Y (TTM)655.84%
Revenue growth 3Y9.01%
Revenue growth 5Y-37.71%
Sales Q2Q%610.96%
Revenue Next Year316.67%
Revenue Next 2Y356.44%
Revenue Next 3Y278.37%
Revenue Next 5Y300.17%
EBIT growth 1Y-17.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.13%
EBIT Next 3Y14.13%
EBIT Next 5Y34.22%
FCF growth 1Y-48.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.97%
OCF growth 3YN/A
OCF growth 5YN/A

CARBIOS / ALCRB.PA Fundamental Analysis FAQ

What is the fundamental rating for ALCRB stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALCRB.PA.


What is the valuation status for ALCRB stock?

ChartMill assigns a valuation rating of 0 / 10 to CARBIOS (ALCRB.PA). This can be considered as Overvalued.


How profitable is CARBIOS (ALCRB.PA) stock?

CARBIOS (ALCRB.PA) has a profitability rating of 0 / 10.


What is the expected EPS growth for CARBIOS (ALCRB.PA) stock?

The Earnings per Share (EPS) of CARBIOS (ALCRB.PA) is expected to decline by -0.64% in the next year.